The possible mechanism of rhapontigenin influencing antifungal activity on Candida albicans
- Authors
- Kim, Narae; Kim, Jeong-Keun; Hwang, Dahyun; Lim, Young-Hee
- Issue Date
- 1월-2013
- Publisher
- INFORMA HEALTHCARE
- Keywords
- andida albicans; rhapontigenin; antifungal activity; apoptosis; ergosterol
- Citation
- MEDICAL MYCOLOGY, v.51, no.1, pp.45 - 52
- Indexed
- SCIE
SCOPUS
- Journal Title
- MEDICAL MYCOLOGY
- Volume
- 51
- Number
- 1
- Start Page
- 45
- End Page
- 52
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/104372
- DOI
- 10.3109/13693786.2012.689021
- ISSN
- 1369-3786
- Abstract
- Rhapontigenin, an aglycone of rhapontin, was produced by biotransformation and we investigated its antifungal activity against Candida albicans, one of the most important opportunistic fungal pathogens. Rhapontigenin is found to have, in vitro, inhibitory activity with a minimal inhibitory concentration (MIC) value against all test isolates of 128-256 mu g/ml. We detected increased reactive oxygen species (ROS) levels in yeast cultures treated with rhapontigenin at the MIC. Rhapontigenin inhibited DNA, RNA, and protein synthesis, especially RNA synthesis, and induced morphological changes and apoptosis of C. albicans. The apoptotic effect of rhapontigenin on C. albicans at subinhibitory concentrations was higher in the stationary growth phase than in the exponential phase, while the opposite results were noted with amphotericin B. The mechanism of antifungal activity of rhapontigenin may be associated with the generation of ROS that might induce apoptosis and it may also involve the inhibition of ergosterol biosynthesis.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Health Sciences > School of Biosystems and Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.